EyeRisk

Using a systems medicine approach, EYE-RISK aims at identifying risk factors, molecular mechanisms and therapeutic approaches for #AMD #ageing #EUHealthResearch

[EyeRisk @EyeRiskEU]

A video not to miss: Figthing #blindness in the #elderly. #AMD research explained: the European @EyeRiskEU project #h2020 #EUHealthResearch https://t.co/JlDXjcsn4I

[EyeRisk @EyeRiskEU]

On December 17, 2020 Thomas Johannes Heesterbeek, MD, PhD Candidate #Ophthalmology bij @radboudumc will defend his thesis at 1.30 pm. To attend the ceremony digitally: https://t.co/xI8RXUywRw. @EyeRiskEU @EU_H2020 #H2020 #HorizonEU #retina #amd #research

[Cabimer @cabimer]

En el Día Internacional de la Visión, CABIMER acerca la I+D en Ciencias de la Visión a la Sociedad. Hoy Jueves 8, a partir de las 11:00. Únete a través de Zoom.
ID de reunión: 719 6050 3939
Código de acceso: Z6TZ06
https://t.co/iTC1AVyp2y

[Fighting Blindness @fight_blindness]

It's #WorldSightDay 2020, an important day to focus global attention on vision impairment. Today we celebrate everyone who is living with a visual impairment, our funded researchers and clinicians, our supporters, members and friends. #HopeinSight #WSD2020

[Prof AJ McKnight @a_j_mcknight]

Looking for an exciting postdoctoral fellowship in data analytics? Currently open for recruitment - project links rich ophthalmic medical and molecular data for AMD. Come join our team! Led by @ruth_hogg @MacularSociety #ISHG @CPH_QUB @QUBPostdoc https://t.co/LXSuPiY0Q3

[EyeRisk @EyeRiskEU]

NOTICE You can watch back it at https://t.co/8p4rE2MfMH!
S12 #Research @JordiMones Lessons learnt from single cell transcriptomics of the #retina. Well defined 3 #GA subgroups driven mainly by #genotypes. Therapeutical strategies should account for this diversity of pathways.

[EyeRisk @EyeRiskEU]

Session 6 #AMD. C. Klaver New insights in #retinal diseases derived from the @EyeRiskEU. This project is able to perform genetic studies to reveal AMD disease pathogenesis & to pool large data material to make incredible large genetic studies. Access at https://t.co/8p4rE2MfMH

[EURETINA @EURETINA]

What an amazing three days we've had at #EURETINA2020! So many excellent presentions and research updates.
Thank you to all our expert speakers and remember you can watch back any sessions you missed at https://t.co/Jintpy5LY7 until the end of the year.

[Rosana Leiva @RosanaLeivaM]

Prof. Caroline Klaver shared really interesting results from her investigations on Geographic Atrphy #GA #AMD
‼️ “44% of GA patients die with a severe visual impairment, this should be our focus group to improve their quality of life”
#euretina2020 @EURETINA

[Rosana Leiva @RosanaLeivaM]

Excellent talk by @JordiMones sharing results from the EyeRisk study 👉🏼 Well defined 3 different #GA subgroups driven mainly by genotypes 💊”Therapeutical strategies should account for this diversity of pathways + develop individualized approaches” #AMD #euretina2020 @EURETINA

[BCNMaculaFoundation @BCNMaculaFoundE]

We are extremely proud and honoured to have ben part of this amazing team @EyeRiskEU #EUResearch #H2020

[EURETINA @EURETINA]

SATURDAY AT #EURETINA2020 Virtual - A full schedule awaits! With so much to choose from you will be glad that you will have access to all the sessions until the end of the year!
Login: https://t.co/JDoHhzySpd

[Young Retina Specialists @YoungRetina]

The @EyeRiskEU group is able to pool large data material to make incredible large genetic studies #euretina2020

[EURETINA @EURETINA]

@EyeRiskEU is able to perform genetic studies to reveal AMD disease pathogenesis, Prof. Klaver presents #EURETINA2020

[EURETINA @EURETINA]

The opening session of #EURETINA2020 has started! Our President Prof Frank G. Holz is now speaking. Welcoming everyone to this year's meeting, he reveals details of the research prize winners and the Society's new 2020-2025 roadmap. More details at https://t.co/Jintpy5LY7.

[EURETINA @EURETINA]

#EURETINA2020 Virtual, 2-4 October. Are you registered yet? *Register before the 25th September to avail of the early registration fee. https://t.co/Jintpy5LY7